^Frishman WH, Goldberg RJ, Benfield P (ianuarie 1988). „Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris”. Drugs. 35 (1): 1–21. doi:10.2165/00003495-198835010-00001. PMID2894292.
^Vaughan Williams EM (iulie 1987). „Bevantolol: a beta-1 adrenoceptor antagonist with unique additional actions”. Journal of Clinical Pharmacology. 27 (7): 450–60. doi:10.1002/j.1552-4604.1987.tb03049.x. PMID2888789.